Malcolm Eade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spectra Plasmonics founder Malcolm Eade on how real-time information is essential in tackling the opioid crisis.

As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs. Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl. The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across...

Author of the article: Elliot Ferguson Publishing date: Dec 16, 2020  •  December 16, 2020  •  3 minute read Malcolm Eade of Spectra Plasmonics explains how the company's drug-checking technology works to a Kingston city council online meeting on Tuesday. Article content KINGSTON — A city-funded pilot project to create an early warning system to detect toxic street drugs could “revolutionize” how local public officials protect drug users. City council approved spending almost $270,000 to support a pilot project at Kingston Community Health Centres designed to allow drug use...